Stock Earnings

Question 1

Adaptive Biotechnologies Corpの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Adaptive Biotechnologies Corpの総資産は$539で、純lossは$-159です。

Question 2

ADPTの主要な財務比率は何ですか？

Accepted Answer

Adaptive Biotechnologies Corpの流動比率は1.6、純利益率は-89.32、1株当たり売上高は$1.21です。

Question 3

Adaptive Biotechnologies Corpの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Adaptive Biotechnologies Corp largest revenue segment is Minimal Residual Disease - Service, at a revenue of 133,029,000 in the most earnings release.For geography, United States is the primary market for Adaptive Biotechnologies Corp, at a revenue of 178,957,000.

Question 4

Adaptive Biotechnologies Corpは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、Adaptive Biotechnologies Corpの純lossは$-159です。

Question 5

Adaptive Biotechnologies Corpに負債はありますか？

Accepted Answer

yes、Adaptive Biotechnologies Corpの負債は336です。

Question 6

Adaptive Biotechnologies Corpの発行済株式数は何株ですか？

Accepted Answer

Adaptive Biotechnologies Corpの総発行済株式数は147.77株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	252	178	170	185	154	98
Revenue Growth (YoY)	42%	5%	-8%	20%	56.99%	15%
Cost of Revenue	71	72	75	57	49	22
Gross Profit	181	106	94	127	105	75
Selling, General & Admin	163	157	172	183	170	110
Research & Development	85	94	109	122	142	116
Operating Expenses	259	262	296	326	314	228
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-79	-159	-225	-200	-207	-146
Income Tax Expense	--	--	--	--	--	--
Net Income	-79	-159	-225	-200	-207	-146
Net Income Growth	-59%	-28.99%	13%	-3%	42%	112%
Shares Outstanding (Diluted)	163.16	147.1	144.38	142.5	140.4	131.2
Shares Change (YoY)	10%	2%	1%	2%	7%	5%
EPS (Diluted)	-0.48	-1.08	-1.56	-1.4	-1.48	-1.11
EPS Growth	-64%	-31%	11%	-5%	33%	98%
Free Cash Flow	-62	-98	-167	-200	-254	-168
Free Cash Flow Per Share	-0.37	-0.66	-1.15	-1.4	-1.8	-1.28
Gross Margin	71.82%	59.55%	55.29%	68.64%	68.18%	76.53%
Operating Margin	-30.95%	-87.07%	-118.23%	-107.02%	-135.71%	-155.1%
Profit Margin	-31.34%	-89.32%	-132.35%	-108.1%	-134.41%	-148.97%
Free Cash Flow Margin	-24.6%	-55.05%	-98.23%	-108.1%	-164.93%	-171.42%
EBITDA	-67	-145	-187	-178	-208	-151
EBITDA Margin	-26.58%	-81.46%	-110%	-96.21%	-135.06%	-154.08%
D&A For EBITDA	11	10	14	20	1	1
EBIT	-78	-155	-201	-198	-209	-152
EBIT Margin	-30.95%	-87.07%	-118.23%	-107.02%	-135.71%	-155.1%
Effective Tax Rate	--	--	--	--	--	--

Adaptive Biotechnologies Corp (ADPT) Price

ADPT Stock Price Chart

ADPT Income

Follow-Up Questions